Upvote
Downvote
Director, Combinational Product Quality
Share Job
- Suggest Revision
Full-time
- Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep, and durable knockdown of target genes.
- RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein.
- Arrowhead is leading the field in bringing the promise of RNAi to address diseases outside of the liver, and our clinical pipeline includes disease targets in the liver and lung with a promising pipeline of preclinical candidates.
- This position will report to the Vice President Quality and Compliance and work closely with members of the Operations, Supply Chain, Regulatory, Quality, and Commercial teams, as well as external stakeholders and suppliers to support Quality Management System (QMS) and ensure the clinical and commercial presentations of combinational product quality and compliance with relevant laws and company's strategic goals.
- Serve as an internal subject matter expert in the combinational products and primary lead for all relevant elements of QMS and quality aspects of the combinational product development and management
Active Job
Updated YesterdaySimilar Job
Relevance
Active